Global Alopecia Treatment (Hair Loss) Market is Expected to Register a Healthy CAGR in the Forecast Period of 2019 to 2026

According to Data Bridge Market Research new Market report, global alopecia treatment (Hair Loss) market will account to reach an estimated USD 8.21 billion in 2018 growing at a CAGR of 5.3% during the forecast period of 2019 to 2026.

Access Full Report at

Global Alopecia Treatment (Hair Loss) Market

Alopecia areata is a disease in which a person hair falls out in large amount in round patches. This happens when the immune system start attacking the hair follicles which causes hair breakage or fall. The scalp of the patient usually became erratic, mingling and patchy. Alopecia areata is a non-curable disease but the lost hair can grow back with treatments like corticosteroids, topical immunotherapy, minoxidil etc.

Segmentation: Global Alopecia Treatment (Hair Loss) Market

Global alopecia treatment (Hair Loss) market is segmented on the basis of disease type, drug type, gender, route of administration, distribution channel and geography.

By Disease Type (Androgenic Alopecia, Alopecia Areata, Ciatricial Alopecia, Traction Alopecia, Alopecia Totalis), Drug Type (Minoxidil, Finasteride, Cyclosporine and Others), Gender (Male, Female), Route of Administration (Oral, Topical, Injectable), Distribution Channel (Hospital, Retail Pharmacies, Online Pharmacies), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa)


Rising Geriatric Population

According to United Nations Department of Economic and Social Affairs/Population Division; in 2017, estimated population of people with age 60 or above was 962 million, which means around 13 per cent of the population. This age bracket or group is growing at a rate of 3 per cent every year. Presently, Europe is leading the other regions in terms of population consisting of this age group. This brisk speed of ageing is expected to carry on in other regions as well, which projects that by the end of 2050 excluding Africa all regions of the world would have more than a quarter share of their total population at an age of 60 years and above. The population of this age group is projected to reach around 1.40 billion in 2030 and 2.10 billion in 2050, and could ultimately rise up to 3.10 billion in 2100.

Key Market Competitors: Global Alopecia Treatment (Hair Loss) Market

Few of the major market competitors currently working in the alopecia treatment (hair loss) market are Cipla, Viviscal, Dr. Reddy’s Laboratories Ltd., Regaine, Merck & Co., Inc, Ranbaxy Laboratories Ltd, Phyto – Alès Groupe, Kirkland Signature, Vitabiotics, Nanogen, Alpecin – Dr. Kurt Wolff GmbH & Co. KG, Rogaine – Johnson and Johnson, Histogen, Inc., Aclaris Therapeutics, Inc., Concert Pharmaceuticals, Inc., HCell Inc., GlaxoSmithKline plc., Perrigo Company PLC. and Daiichi Sankyo, Inc.

Browse Related Reports:

Global Infertility Treatment Market By Procedure {ART, Artificial Insemination, IVF, Surrogacy, Fertility Surgery (Laparoscopy, Hysteroscopy)}, Product {Instruments (Microscopes, Imaging Systems, Sperm Analyzer Systems), Media, Accessories}, Patient Type (Male, Female), End User (Fertility Clinics, Hospitals, Cryobanks), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends & Forecast to 2026

Global bleeding disorders treatment Market By Drug type (Plasma-derived Coagulation Factor Concentrates, Recombinant Coagulation Factor Concentrates, Desmopressin, Antifibrinolytics, Fibrin Sealants, Others), Disease type (Hemophilia A, Hemophilia B, Von Willebrand Disease, Liver Disease, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Compounding Pharmacies) End User (Clinics, Hospitals & Academic Institutions), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends & Forecast to 2026